SILO PHARMA, INC. Retained Earnings
SILO PHARMA, INC. (SILO) had Retained Earnings of -$21.97 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$21.97M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$21.14M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$19.49M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$18.61M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$21.97M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$21.14M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$19.49M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$18.61M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$17.50M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$16.30M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$15.26M POS AM · filed 2026-04-14 |
| 2024-09-30 | -$13.53M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$12.61M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$11.67M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$10.87M 10-K · filed 2025-03-28 |
| 2023-09-30 | -$9.75M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$9.09M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$8.08M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$7.17M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$5.51M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$4.53M 10-Q · filed 2022-08-01 |
| 2022-03-31 | -$3.87M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$3.26M 10-K · filed 2023-03-24 |
| 2021-09-30 | -$2.17M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$8.56M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$8.10M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$5.76M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$4.97M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$4.34M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$2.89M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$2.66M 10-K/A · filed 2021-05-17 |
| 2019-09-30 | -$2.27M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$2.01M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$1.77M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$1.64M 10-K · filed 2020-03-20 |
| 2018-09-30 | -$1.17M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |